Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fridman
Amir Fridman, Tel Aviv IL
| Patent application number | Description | Published |
|---|---|---|
| 20110040918 | Host for Use with Dual Interface Card with Backward and Forward Compatibility - Techniques are presented that allow a memory card operable according to two protocols (such as a legacy protocol and newer protocol), and having a corresponding dual interface, to be used with hosts that support the new protocol as well as having backward compatibility with legacy hosts, while preventing the use of legacy cards with hosts that support the new protocol but do not support the legacy protocol. The card that supports the new protocol has a similar form factor to the legacy card, includes an indentation. A host that supports the new, but not the legacy, type card includes a mechanical structure within the attachment slot that, based on the card indentation, can distinguish the card types and prevent the non-supported card from being attached. | 02-17-2011 |
| 20110072185 | MULTI-PROTOCOL STORAGE DEVICE BRIDGE - A bridge includes a host interface via which data/commands are received from and transferred to a host, and a storage device interface via which data/commands are received from and transferred to a storage device. The bridge also includes one SDPC, a controller and a switching system that is configurable by the controller to connect the protocol converter to the host interface and the storage device interface if the storage device protocol used by the host device differs from the storage device protocol used by the storage device, and to connect the host device interface to the storage device interface, not via the bi-directional protocol converter, if the two storage device protocols are the same. The bridge may include two SDPCs, each for converting a different protocol to the host protocol and vice versa, with the switching system being configurable to switch between the two SDPCs. The bridge may omit the SDPC altogether, with the switching system being configurable to switch between connecting (1) the host device interface to the storage device interface, and (2) bypassing the storage device interface. | 03-24-2011 |
| 20110189866 | Dual Interface Card with Backward and Forward Compatibility - Techniques are presented that allow a memory card operable according to two protocols (such as a legacy protocol and newer protocol), and having a corresponding dual interface, to be used with hosts that support the new protocol as well as having backward compatibility with legacy hosts, while preventing the use of legacy cards with hosts that support the new protocol but do not support the legacy protocol. The card that supports the new protocol has a similar form factor to the legacy card, includes an indentation. A host that supports the new, but not the legacy, type card includes a mechanical structure within the attachment slot that, based on the card indentation, can distinguish the card types and prevent the non-supported card from being attached. | 08-04-2011 |
Catherine Fridman, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20120100133 | USE OF ANTI-CD20 ANTIBODY FOR TREATING PRIMARY INTRAOCULAR LYMPHOMA - An embodiment relates to a monoclonal antibody directed against the CD20 antgen, in which the variable region of each of the light chains is coded by murine nucleic acid sequence SEQ ID NO:1, the variable region of each of the heavy chains is coded by murine nucleic acid sequence SEQ ID NO: 2, and the constant regions of the light chains and of the heavy chains originate from a non-murine species, said antibody being used for treating primary intraocular lymphoma. | 04-26-2012 |
Herve Fridman, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110195923 | Methods for Predicting the Response to Anti-Cancer Treatment with an Agonist of TLR7 or an Agonist of TLR8 - The present invention relates to methods for predicting the response to treatment with an agonist of TLR7, or an agonist of TLR8 or an anti-cancer agent for treating cancer, in particular non-small cell lung cancer comprising the step of detecting the expression of TLR7 or TLR8 in cancer cells of said patient. | 08-11-2011 |
Natalie Fridman, Petach Tikva IL
| Patent application number | Description | Published |
|---|---|---|
| 20090265299 | COMPUTING SOLUTIONS TO PROBLEMS USING DYNAMIC ASSOCIATION BETWEEN ABSTRACT GRAPHS - A device, system, and method for solving a plurality of sub-problems representing a main problem pertaining to an environment. An abstract graph corresponding to each of the sub-problems may be constructed in a computing system for each of the sub-problems. At least a first abstract graph of the abstract graphs may be resolved, for example, by decomposing one or more nodes of the first abstract graph. At least one of the one or more nodes of the first abstract graph may be associated with one or more nodes of others of the abstract graphs. At least one of the abstract graphs may be resolved using information obtained by the association. Other embodiments are described and claimed. | 10-22-2009 |
Ofer Fridman, Lotem IL
| Patent application number | Description | Published |
|---|---|---|
| 20100030057 | IMAGING CATHETER - A catheter for conveying flowables in or out of the body, be they gases or liquids. The catheter has a triangular lumen and optional auxiliary structures. One optional element is guide engaging for employing a guide for placing the catheter. Another element is a secondary lumen disposed within the wall of the tube. The camera and lighting devices at the tip of the catheter are mounted on a partially flexible PCB and packaged in the tube permitting all elements to point substantially forwards. | 02-04-2010 |
Ofer Fridman, D.n. Bikat Beit Hakerem IL
| Patent application number | Description | Published |
|---|---|---|
| 20100280545 | SYSTEM AND METHOD FOR BONDING LIVING TISSUE - A system for bonding living tissue including first tissue displacer functionality operative initially to cause displacement of edges of tissue into a mutual touching relationship along a seam prior to bonding thereof and second tissue displacer functionality operative following operation of the first tissue displacer functionality to cause displacement of the edges into a mutual non-touching relationship wherein the edges are in mutual propinquity. | 11-04-2010 |
Ofer Fridman, Bikat Beit Hakerem IL
| Patent application number | Description | Published |
|---|---|---|
| 20100087804 | SYSTEM AND METHOD FOR TREATING TISSUE - A method and system for tissue treatment, wherein the method includes transmitting energy onto tissue to be treated, and maintaining a required distance, during the tissue treatment, between a hand piece and the tissue. The method may further include applying a soldering agent for facilitating tissue soldering, used as adhesive to various types of protein in human tissue, wherein the transmitting energy activates the soldering agent applied on the tissue. | 04-08-2010 |
Sharon Fridman, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20100057767 | SYSTEM AND METHOD FOR DYNAMICALLY CREATING AND/OR UPDATING SUBSCRIBER COMMUNICATIONS LISTS - A system and method are disclosed herein for dynamically updating a first subscriber communications list or creating a new subscriber communications list based on awareness information data, the method comprising creating a rule for defining a second subscriber communications list, the second subscriber communications list being an updated first subscriber communications list or being a created new subscriber communications list; storing the rule; retrieving and pre-processing existing data; retrieving and pre-processing the awareness information data; and storing the second subscriber communications list. | 03-04-2010 |
| 20110022444 | SYSTEM AND METHOD FOR ASSESSING MOBILE APPLICATION VALUE - A method and system for assessing a value of a first application with respect to a use of a mobile communication device in communication with a second communication device are presented. The method entails assigning a set of proximity values that relate the use of the application to the communication between the mobile communication device and the second communication device, and determining an impact and a value based on the proximity values. The proximity values may include a relationship proximity value, a time proximity value, a geographical proximity value, an action proximity value, and one or more user-defined proximity values. The determined value may be expressed as a monetary value. | 01-27-2011 |
Tzvika Fridman, Kiryat Ono IL
| Patent application number | Description | Published |
|---|---|---|
| 20100028134 | QUIET FAN INCORPORATING ACTIVE NOISE CONTROL (ANC) - An active noise control (ANC) system may be implemented to both sides of a fan, such that both directions of the noise emitting are treated to reduce the overall noise. The impact on airflow is minimal, and the technique is very effective in a broad range of low frequencies. Passive sound-absorbing materials may be included for attenuation of high frequencies. The resulting quiet fan produces a low level of noise compared to any other device based on fan, which produces the same capacity of airflow. The quiet fan may be incorporated in any mechanical system which requires airflow induction such as: computers, air conditioners, machines, and more. | 02-04-2010 |
Wolf-Herman Fridman, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090215053 | Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method - The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of the presence of, or alternatively the level of, the adaptive immune response of said patient against said cancer. | 08-27-2009 |
| 20110178069 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME - The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-γ-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-γ-mediated diseases and decreasing IGIF and IFN-γ production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds. | 07-21-2011 |
Wolf Herve Fridman, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100196418 | UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS - The present invention concerns an universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein: | 08-05-2010 |